BeiGene announced that the company will issue 866,073 new shares to its wholly-owned subsidiary BGNC2 to increase the share capital. The new shares will be transferred to the company and held for the benefit of participants in the 2018 Employee Stock Purchase Plan until the end of the subscription period from March 2 to August 31, 2026. Approximately 4,694 employees participated. After the new shares are fully issued, they are equal to the shares already issued, but they have no voting rights or partial dividend rights before delivery, and there is no equity dilution. Additionally, the company will amend the Swiss Constitution to reflect this increase in share capital.

BeiGene announced that the company will issue 866,073 new shares to its wholly-owned subsidiary BGNC2 to increase the share capital. The new shares will be transferred to the company and held for the benefit of participants in the 2018 Employee Stock Purchase Plan until the end of the subscription period from March 2 to August 31, 2026. Approximately 4,694 employees participated. After the new shares are fully issued, they are equal to the shares already issued, but they have no voting rights or partial dividend rights before delivery, and there is no equity dilution. Additionally, the company will amend the Swiss Constitution to reflect this increase in share capital.